VKH
AMAG

Virtu KCG Holdings’s AMAG Pharmaceuticals AMAG Stock Holding History

Virtu KCG Holdings’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-14,107
Closed -$491K – 3987
2016
Q4 		$491K Buy
+14,107
New +$421K 0.01% 1514
2016
Q3 		– Sell
-12,327
Closed -$295K – 3629
2016
Q2 		$295K Buy
+12,327
New +$283K 0.01% 1896
2015
Q4 		– Sell
-5,700
Closed -$226K – 4093
2015
Q3 		$226K Sell
5,700
-8,166
-59% -$507K ﹤0.01% 2437
2015
Q2 		$958K Sell
13,866
-9,610
-41% -$605K 0.02% 887
2015
Q1 		$1.28M Buy
+23,476
New +$1.12M 0.03% 600
2014
Q4 		– Sell
-10,626
Closed -$339K – 4386
2014
Q3 		$339K Buy
+10,626
New +$227K 0.01% 2182

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virtu KCG Holdings's AMAG Position: Q1 2017 in Review

Virtu KCG Holdings sold out of AMAG Pharmaceuticals (AMAG) in Q1 2017, closing a stake of 14,107 shares — an estimated $491K sold.

Virtu KCG Holdings first reported a position in AMAG in Q3 2014 and held it in 6 quarters. The position peaked at $1.28M in Q1 2015. 185 funds tracked by Wall St. Rank hold AMAG as of Q1 2017.

  • Virtu KCG Holdings reported no remaining AMAG Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 14,107 AMAG Pharmaceuticals shares in Q1 2017, an estimated $491K.
  • Virtu KCG Holdings first reported a position in AMAG Pharmaceuticals in Q3 2014 and held it in 6 quarters.
  • Virtu KCG Holdings's AMAG Pharmaceuticals position peaked at $1.28M in Q1 2015.
  • 185 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2017.

Based on Virtu KCG Holdings's 13F filing for Q1 2017, filed 12 May 2017.